Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116082296B reveals monopersulfate catalysis for benzothiophene. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN117025574A reveals high-activity dipeptidase for L-Carnosine. Green enzymatic route offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106146535A reveals a novel Lewis acid-catalyzed route for Everolimus. This method ensures high purity, reduced steps, and scalable supply chain reliability for global buyers.
Patent CN107653273B reveals a dual-enzyme one-pot method for high-yield benzoquinone synthesis, offering green manufacturing and cost reduction for pharmaceutical intermediates.
Patent CN108659046B reveals a robust route for tetramethyl spiroindane ligands. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis.
Patent CN114369048A reveals a novel Wittig route for high-purity astaxanthin, offering significant cost reduction and supply chain stability for global manufacturers.
Patent CN101709023A details a novel synthesis for 2,2',6,6'-tetrahydroxy biphenyl ligands, offering high yields and simplified chiral catalyst production for pharmaceutical applications.
Advanced patent CN102164932A enables halogen-free flame retardant intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for polymer additives.
Patent CN103695486A reveals a novel one-pot enzymatic route for Atorvastatin intermediates, offering significant cost reduction and safer manufacturing for global API producers.
Patent CN106977488B reveals visible light promoted synthesis. Offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chains.
Novel biocatalytic route for sitagliptin intermediates offers high ee value and green manufacturing advantages for pharmaceutical supply chains globally.
Novel enzymatic process ensures 95-100% purity. Reduces oxidation risks and offers scalable solutions for nutritional ingredients manufacturing.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.
Novel enzymatic resolution route for high-purity Alzheimer's intermediate. Reduces cost and improves scalability for pharma manufacturing.
Patent CN102154377B reveals ScCR enzyme for asymmetric reduction. Enables cost-effective manufacturing of pharmaceutical intermediates with self-regenerating cofactors.
Patent CN106674277A reveals a novel Fe-Cu catalyzed method for olefin phosphate synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112458143B reveals a novel whole-cell catalytic route for Ezetimibe intermediates. Discover how this green biocatalysis technology reduces costs and ensures supply chain stability.
Patent CN110818733B reveals a high-efficiency disilylamine rare earth complex for hydroboration, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN105017110B reveals a cost-effective synthesis route for trifluoromethylthio reagents, offering significant supply chain stability and purity advantages for global pharmaceutical intermediates manufacturing.
Patent CN112961166A reveals a novel rare-earth catalyzed one-pot route for pyrano[2,3-b]indol-2-ones, offering significant cost reduction in pharmaceutical intermediate manufacturing.